GLP-1 Providers in Nevada (2026)

362 of the 444 sellers that publish a state list include Nevada, the 11th-most of the 50 states and DC. 226 of them ship to all 50 states, and 6 serve 15 states or fewer. Across the 247 with a regular monthly price, the middle figure is $169/mo.

Nevada Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Sellers and prices are broken out by drug on the semaglutide in Nevada and tirzepatide in Nevada pages.

Who Ships GLP-1s to Nevada

1. WellMedRx $49/mo
2. Collective $59/mo
3. RxPepsDirect $64/mo

Lowest regular prices for Nevada: WellMedRx at $49/mo, Collective at $59/mo and RxPepsDirect at $64/mo.

Smaller-footprint sellers that include Nevada: LiveNow Longevity (1 state), AquaVita NextGen (5 states), Intermountain Health On-Demand Weight Loss (6 states), The Virtual NP (7 states) and JM Integrated Health (8 states), plus 1 more.

4 sellers that list 30 or more states leave Nevada off, among them BMI Doctors, Welm Health, Care Clinics and Fierce Health.

Seller counts next door: Arizona 378, California 346, Idaho 355, Oregon 353 and Utah 362.

Browse by medication

Nevada Medicaid and GLP-1 Coverage

Nevada Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

• Wegovy to cut heart attack and stroke risk: covered with prior authorization (a BMI of at least 27; prior heart attack, prior ischemic or hemorrhagic stroke, symptomatic peripheral artery disease, or specialist-verified established cardiovascular disease; age of at least 18; no type 1 diabetes/type 2 diabetes; prescribed by or with a cardiologist or vascular specialist; lifestyle counseling documented).
• Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2, F3).
• Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a BMI of at least 30; AHI of 5+ also qualifies with symptoms such as daytime sleepiness or snoring; ongoing CPAP or BiPAP use, not a failed trial).
• Weight-loss GLP-1s for adolescents: not covered.

In 2025, Nevada Medicaid paid for at least 70,791 GLP-1 prescriptions, including at least 42,402 for Ozempic, at least 876 for Wegovy, at least 19,176 for Mounjaro and at least 364 for Zepbound, about $81.7 million before manufacturer rebates. Drugs labeled for weight loss made up 2% of that spending.

Medicaid rules checked November 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Nevada

Nevada has 277 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 8.48 per 100,000 residents (27th of 51). By specialty: 154 bariatric, 120 endocrinology and 3 obesity medicine. About 34.2% of adults here had obesity in 2024 (CDC), the 24th-highest rate of the 50 states and DC. Measured against the median state, Nevada has 1 times as much adult obesity per specialist practice.

Largest Cities in Nevada

Frequently Asked Questions